Skip to main content
TipRanks
Go Ultimate75% OFF

Hotel Royal Chihpen (5704) AI Stock Analysis

TW:5704

Hotel Royal Chihpen

(TPEx:5704)

Select Model
Rating:53Neutral
Price Target:TWD 21.00▼(-0.24% Downside)
Action:initiatedcoverage
Date:11/10/26

The score is primarily supported by the exceptionally strong balance sheet, but profitability deterioration and negative free cash flow are significant concerns. Weak technical momentum and a high P/E ratio further limit the stock's attractiveness.

Positive Factors
Very low leverageExtremely low leverage reduces financial risk and interest burden, giving the hotel greater resilience through lodging cycles. A substantial and fairly stable equity base also supports asset coverage and preserves flexibility to fund operations or measured investment without relying heavily on new debt.
Negative Factors
Persistent negative free cash flowNegative free cash flow for two consecutive years shows that recent operations have not fully funded reinvestment or working-capital needs. Even with low leverage, continued cash outflows can reduce liquidity over time and constrain the company’s ability to maintain or expand the resort without using existing cash.

Hotel Royal Chihpen (5704) vs. SPDR S&P 500 ETF (SPY)

-20%-15%-10%-5%0%5%10%15%20%TW:5704-16.02%SPY+14.28%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
TWD 1.29B
Dividend Yield
―
Average Volume (3M)
41.05K
Price to Earnings (P/E)
61.9
Beta (1Y)
0.31
Revenue Growth
10.31%
EPS Growth
―
Country
TW
Employees
198
Sector
General
Sector Strength
55
Industry
Travel Lodging

Hotel Royal Chihpen Business Overview & Revenue Model

Company Description

Hotel Royal Chihpen manages a resort property situated in Taiwan. This establishment offers various visitor accommodations, alongside diverse recreational facilities and amenities for its guests. The firm's operational base is located in Taitung, Tai...

Hotel Royal Chihpen Financial Statement Overview

Summary

The company has a very strong, low-debt balance sheet, but weaker operating profitability and negative free cash flow materially reduce the overall financial score.

Income Statement

55Neutral

Balance Sheet

91Very Positive

Cash Flow

43Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Sep 2023Dec 2022Dec 2021
Income Statement
Total Revenue297.10M327.59M351.51M467.19M478.86M362.50M
Gross Profit114.84M131.25M140.44M230.76M239.95M155.19M
EBITDA29.19M43.73M50.54M160.28M143.99M95.90M
Net Income8.01M15.16M15.89M115.77M94.91M58.64M
Balance Sheet
Total Assets1.11B751.87M693.96M770.65M723.65M661.95M
Cash, Cash Equivalents and Short-Term Investments324.35M284.34M302.84M352.95M346.62M259.81M
Total Debt1.93M2.48M507.00K1.65M2.24M958.00K
Total Liabilities131.24M196.67M156.04M191.46M173.35M153.88M
Stockholders Equity980.12M555.20M537.92M579.20M550.30M508.06M
Cash Flow
Free Cash Flow-356.82M-17.10M-21.86M93.41M140.94M48.28M
Operating Cash Flow36.28M57.92M28.98M118.87M143.57M51.77M
Investing Cash Flow-319.04M-55.64M-63.31M3.79M-30.63M19.18M
Financing Cash Flow438.94M-830.00K-59.45M-87.08M-54.55M-86.59M

Hotel Royal Chihpen Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

TW:5704 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TW:6961TW:696162NeutralTWD 1.07B15.43―12.50%――
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
TW:5704TW:570453NeutralTWD 1.25B61.91――10.31%―
TW:6219TW:621945NeutralTWD 1.29B11.01―6.44%9.98%-32.64%
TW:2719TW:271944NeutralTWD 1.25B17.03――-20.72%―
TW:2712TW:271243NeutralTWD 1.29B-47.32――25.09%72.18%

* General Sector Average

Performance Comparison

-40%-20%0%20%40%TW:5704TW:2712TW:2719TW:4195TW:6219TW:6961Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TW:5704 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TW:5704Hotel Royal Chihpen21.05-3.88-15.55%
TW:2712Far Glory Hotel Co., Ltd.12.35-6.90-35.84%
TW:2719TSG Star Travel Corp18.05-16.95-48.43%
TW:4195Genomics BioSci & Tech. Co., Ltd.14.90-9.70-39.43%
TW:6219Full Wang International Development Co. Ltd.10.40-9.55-47.87%
TW:6961Uni Travel Services Co. Ltd.40.00-31.00-43.67%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 10, 2026